Chimeric toxins targeted to the human immunodeficiency virus type 1 envelope glycoprotein augment the in vivo activity of combination antiretroviral therapy in thy/liv-SCID-Hu mice (Q45743776)
scientific article published in March 2000
Language:
(P31) (Q13442814)
(P304) 921-926
(P407) (Q1860)
(P433) 3
(P478) 181
(P577) Wednesday, March 1, 2000
(P1433) (Q4051141)
(P1476) "Chimeric toxins targeted to the human immunodeficiency virus type 1 envelope glycoprotein augment the in vivo activity of combination antiretroviral therapy in thy/liv-SCID-Hu mice" (language: en)
(P2093) Goldstein H
Pettoello-Mantovani M
Bera TK
Pastan IH
Berger EA
other details
description scientific article published in March 2000

External Links